Drug Markets/Zavegepant

Zavegepant

1 NDC across 1 manufacturer|0 Generic,1 Brand

Zavegepant is used to treat migraine with aura and migraine without aura, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Zavegepant is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $189.80 to $189.80 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$189.80 – $189.80

per EA

7d Activity

1↓0 flat

avg -0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ZAVEGEPANT

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
ZAVZPRET 10 MG NASAL SPRAY
$189.8006
per EA
-0.01%

Frequently Asked Questions

What is Zavegepant used to treat?

Zavegepant is used to treat migraine with aura and migraine without aura, per the National Library of Medicine's MED-RT classification.

How many Zavegepant products are on the market?

The Zavegepant drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Zavegepant?

NADAC reference prices for Zavegepant range from $189.8006 to $189.8006 per EA.

Which manufacturers make Zavegepant?

1 manufacturer lists Zavegepant in NADAC. Ranked by number of NDCs, the largest are Pfizer Inc. (1).

How has the price of Zavegepant changed recently?

Over the past 7 days, 0 Zavegepant NDCs rose and 1 fell, with a market-wide average change of -0.0%.